Researching Immunotherapy Side Effects to Improve Treatment
Cancer research and innovative treatments, like immunotherapy, are helping cancer patients with advanced disease live longer.
For 80 years the Department of Psychiatry has provided the highest quality care to adults, children and adolescents, along with pioneering research and education.
Maurizio Fava, MD, Chief of Psychiatry
John B. Herman, MD, Associate Chief
Jeff Huffman, MD, Associate Chief for Clinical Services
Sabine Wilhelm, PhD, Chief of Psychology
Timothy E. Wilens, MD, Chief of Child Psychiatry
Janet Wozniak, MD, Associate Chief for Quality and Safety
Gregory L. Fricchione, MD, Associate Chief of Psychiatry
Felicia Smith, MD, Associate Chief for Psychiatry and Medicine
Susan Sprich, PhD, Director of Psychology Training
Isabel Lagomasino, MD, Program Director, MGH/McLean Adult Psychiatry Residence
Deborah Blacker, MD, MSc, Associate Chief for Research
Roy Perlis, MD, Associate Chief for Research
Jordan W. Smoller, MD, MSc, Associate Chief for Research
Lee Cohen, MD, Associate Chief for Philanthropy and Department Communication
Alex Keuroghlian, MD, MPH, Associate Chief for Public and Community Psychiatry
Olivia I. Okereke, MD, MS, Director of the MGH Psychiatry Center for Racial Equity and Justice
A. Eden Evins, MD, MPH, Director for Faculty Development
Joy B. Rosen, Vice President
Laurie Ansorge Ball, Executive Director
U.S. News & World Report rates Mass General Psychiatry the top in the nation.
Resources for patients and families including educational programs and information about mental health issues from the Department of Psychiatry.
Advances in Motion highlights the latest breakthroughs, research and clinical trials from Mass General.
Cancer research and innovative treatments, like immunotherapy, are helping cancer patients with advanced disease live longer.
Physician-scientists at Massachusetts General Hospital are leading a clinical trial assessing the effectiveness of cell therapy to reinforce weakened tissue associated with fecal incontinence.
A recently completed phase 3 clinical trial, conducted by researchers at Mass General Brigham and collaborators, shows that combining inavolisib with palbociclib and fulvestrant improves overall survival for patients with advanced PIK3CA-mutated breast cancer.
Researchers from Mass General Brigham will present research discoveries and outcomes from clinical trials in cancer at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, held May 30-June 3 in Chicago.
A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow transplant.
Cancer research and innovative treatments, like immunotherapy, are helping cancer patients with advanced disease live longer.
Physician-scientists at Massachusetts General Hospital are leading a clinical trial assessing the effectiveness of cell therapy to reinforce weakened tissue associated with fecal incontinence.
A recently completed phase 3 clinical trial, conducted by researchers at Mass General Brigham and collaborators, shows that combining inavolisib with palbociclib and fulvestrant improves overall survival for patients with advanced PIK3CA-mutated breast cancer.
Neuroscience Advances in Motion is an update for health care professionals from specialists at Massachusetts General Hospital on research and clinical advances in psychiatry, neurology and neurosurgery.